𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The neutrophil in rheumatoid arthritis: Its role and the inhibition of its activation by nonsteroidal antiinflammatory drugs

✍ Scribed by S. Abramson; H. Edelson; H. Kaplan; W. Given; G. Weissmann

Book ID
113214183
Publisher
Elsevier Science
Year
1983
Tongue
English
Weight
506 KB
Volume
13
Category
Article
ISSN
0049-0172

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The rise and decline of nonsteroidal ant
The rise and decline of nonsteroidal antiinflammatory drug–associated gastropathy in rheumatoid arthritis
✍ James F. Fries; Kirsten N. Murtagh; Mihoko Bennett; Ernesto Zatarain; Bharathi L πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 109 KB πŸ‘ 2 views

## Abstract ## Objective Nonsteroidal antiinflammatory drug (NSAID)–associated gastropathy is a major cause of hospitalization and death. This study was undertaken to examine whether recent preventive approaches have been associated with a declining incidence of NSAID gastropathy, and, if so, what

Tenidap, in contrast to several availabl
Tenidap, in contrast to several available nonsteroidal antiinflammatory drugs, potently inhibits the release of activated neutrophil collagenase
✍ Warren D. Blackburn Jr.; Louis W. Heck; Leland D. Loose; W. Winn Chatham πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 621 KB

Neutrophils contain a collagenase that is stored in a latent form within the specific granule. With cellular activation, the latent enzyme is activated in association with the production of a variety of oxidants, including hypochlorous acid. We evaluated 4 nonsteroidal antiinflammatory drugs (NSAIDs

Genetic predictors of patient response a
Genetic predictors of patient response and side effects in the treatment of rheumatoid arthritis with a high dose nonsteroidal antiinflammatory drug regimen
✍ Elliott Semble; Douglas Metcalf; Robert Turner; Carlos Agudelo; Edward Pisko; A. πŸ“‚ Article πŸ“… 1982 πŸ› John Wiley and Sons 🌐 English βš– 462 KB πŸ‘ 2 views

## Abstract Clinical, laboratory, genetic, and radiologic studies were evaluated for 18 patients with rheumatoid arthritis who were treated for a mean of 16.6 months with a regimen involving supplementary aspirin and piroxicam, an investigational, nonsteroidal antiinflammatory agent. Although impro